| Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases M Mehta, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ... Chemico-biological interactions 308, 206-215, 2019 | 758 | 2019 |
| Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy D Tewari, P Patni, A Bishayee, AN Sah, A Bishayee Seminars in cancer biology 80, 1-17, 2022 | 362 | 2022 |
| Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics X Feng, A Sureda, S Jafari, Z Memariani, D Tewari, G Annunziata, ... Theranostics 9 (7), 1923-1951, 2019 | 297 | 2019 |
| Curcumin, the golden spice in treating cardiovascular diseases H Li, A Sureda, HP Devkota, V Pittalà, D Barreca, AS Silva, D Tewari, ... Biotechnology advances 38, 107343, 2020 | 280 | 2020 |
| Review on nanoparticles and nanostructured materials: Bioimaging, biosensing, drug delivery, tissue engineering, antimicrobial, and agro-food applications V Harish, D Tewari, M Gaur, AB Yadav, S Swaroop, M Bechelany, ... Nanomaterials 12 (3), 457, 2022 | 278 | 2022 |
| Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery N Zahin, R Anwar, D Tewari, MT Kabir, A Sajid, B Mathew, MS Uddin, ... Environmental Science and Pollution Research 27 (16), 19151-19168, 2020 | 266 | 2020 |
| Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems M Hajialyani, D Tewari, E Sobarzo-Sánchez, SM Nabavi, MH Farzaei, ... International journal of nanomedicine, 5023-5043, 2018 | 194 | 2018 |
| Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention D Tewari, SF Nabavi, SM Nabavi, A Sureda, AA Farooqi, AG Atanasov, ... Pharmacological Research 128, 366-375, 2018 | 184 | 2018 |
| The role of flavonoids in autoimmune diseases: Therapeutic updates KRR Rengasamy, H Khan, S Gowrishankar, RJL Lagoa, ... Pharmacology & therapeutics 194, 107-131, 2019 | 156 | 2019 |
| Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs D Tewari, AM Stankiewicz, A Mocan, AN Sah, NT Tzvetkov, L Huminiecki, ... Frontiers in aging neuroscience 10, 3, 2018 | 151 | 2018 |
| Circadian and sleep dysfunction in Alzheimer’s disease MS Uddin, D Tewari, A Al Mamun, MT Kabir, K Niaz, MII Wahed, ... Ageing Research Reviews 60, 101046, 2020 | 131 | 2020 |
| Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease MS Uddin, D Tewari, G Sharma, MT Kabir, GE Barreto, MN Bin-Jumah, ... Molecular Neurobiology 57, 2902-2919, 2020 | 125 | 2020 |
| Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches MS Uddin, A Al Mamun, BS Alghamdi, D Tewari, P Jeandet, MS Sarwar, ... Seminars in cancer biology 83, 100-120, 2022 | 120 | 2022 |
| Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways D Wang, P Uhrin, A Mocan, B Waltenberger, JM Breuss, D Tewari, ... Biotechnology advances 36 (6), 1586-1607, 2018 | 113 | 2018 |
| Anthocyanins in the management of metabolic syndrome: A pharmacological and biopharmaceutical review R Naseri, F Farzaei, P Haratipour, SF Nabavi, S Habtemariam, ... Frontiers in Pharmacology 9, 1310, 2018 | 101 | 2018 |
| Role of nitric oxide in neurodegeneration: function, regulation, and inhibition D Tewari, AN Sah, S Bawari, SF Nabavi, AR Dehpour, S Shirooie, ... Current neuropharmacology 19 (2), 114-126, 2021 | 100 | 2021 |
| Down syndrome: Neurobiological alterations and therapeutic targets RA Vacca, S Bawari, D Valenti, D Tewari, SF Nabavi, S Shirooie, AN Sah, ... Neuroscience & Biobehavioral Reviews 98, 234-255, 2019 | 90 | 2019 |
| Nanoparticle and nanostructure synthesis and controlled growth methods V Harish, MM Ansari, D Tewari, M Gaur, AB Yadav, ML García-Betancourt, ... Nanomaterials 12 (18), 3226, 2022 | 85 | 2022 |
| Ethnopharmacological approaches for therapy of jaundice: Part II. Highly used plant species from Acanthaceae, Euphorbiaceae, Asteraceae, Combretaceae, and Fabaceae families D Tewari, A Mocan, ED Parvanov, AN Sah, SM Nabavi, L Huminiecki, ... Frontiers in pharmacology 8, 519, 2017 | 82 | 2017 |
| Big impact of nanoparticles: Analysis of the most cited nanopharmaceuticals and nanonutraceuticals research AWK Yeung, EB Souto, A Durazzo, M Lucarini, E Novellino, D Tewari, ... Current research in Biotechnology 2, 53-63, 2020 | 81 | 2020 |
Archana Negi SahProfessor, Former Head & Dean, Department of Pharmaceutical Sciences, Faculty of在 kunainital.ac.in 的电子邮件经过验证
